Atypical neuroleptic malignant syndrome in H1N1 pneumonia

Ann Clin Psychiatry. 2013 Feb;25(1):69-70.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antimanic Agents / administration & dosage
  • Antimanic Agents / adverse effects
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects
  • Benzodiazepines / administration & dosage
  • Benzodiazepines / adverse effects*
  • Creatine Kinase / blood
  • Haloperidol / administration & dosage
  • Haloperidol / adverse effects
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Male
  • Middle Aged
  • Neuroleptic Malignant Syndrome / blood
  • Neuroleptic Malignant Syndrome / etiology*
  • Neuroleptic Malignant Syndrome / therapy
  • Olanzapine
  • Pneumonia, Viral* / complications
  • Pneumonia, Viral* / etiology
  • Schizophrenia* / complications
  • Schizophrenia* / drug therapy
  • Treatment Outcome
  • Valproic Acid / administration & dosage
  • Valproic Acid / adverse effects
  • Withholding Treatment

Substances

  • Antimanic Agents
  • Antipsychotic Agents
  • Benzodiazepines
  • Valproic Acid
  • Creatine Kinase
  • Haloperidol
  • Olanzapine